3413 results

The Core Team shaping #PCRLV

Seven experienced Course Directors are working together to make this edition of PCR London Valves the best yet! Their objectif: serve the needs of the entire Heart Team.

Key updates in valvular heart disease management: insights from the 2025 ESC/EACTS Guidelines

03 Sep 2025

Alex Sticchi provides his take on the new ESC Valvular Guidelines presented at the ESC Congress 2025 in Madrid.

Author

Alessandro Sticchi

EuroPCR 2025 – Meta-Analysis of Individual Patient Data from the PROTECTED TAVR and BHF PROTECT-TAVI Trials

21 May 2025

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among which is the...

2025 Andreas Grüntzig Ethica Award presented to Lars Wallentin and Stefan James on behalf of Swedish cardiovascular registry experts

20 May 2025

The Andreas Grüntzig Ethica Award is traditionally given to those who have contributed in an extraordinary way to the PCR mission, that of serving the needs of patients by sharing knowledge, experience and practice in cardiovascular interventional medicine.

Mark your agenda now and prepare to join your peers at the next edition on 10-11 December 2025!

Mark your agenda now and prepare to join your peers at the next edition on 10-11 December 2025!

Spotlight on a selection of top Late-breaking Trials presented at PCR London Valves 2025

17 Nov 2025

View a snapshot of the results of these 4 trials in valvular and structural interventions presented in London during this year's Heart Team Course!

The top ten impactful papers from 2025 on tricuspid intervention we almost missed

13 Jan 2026

Transcatheter interventions have rapidly reshaped the management of tricuspid valve disease, with landmark trials establishing feasibility and early clinical benefit.

Beyond these pivotal studies, a series of less visible but highly informative papers addressed mechanisms, complications, patient phenotypes, and unintended consequences of intervention.

This curated selection highlights ten impactful tricuspid...

Author

Alessandro Sticchi

Meril presents successful LANDMARK RCT one-year results at prestigious EuroPCR 2025

21 May 2025

International Women's Day 2025: Raising awareness of aortic stenosis in women: - a silent killer

08 Mar 2025

It was a day in October last year when I had a meeting with patients’ group in UK. At the time, I needed to discuss with them why a registry on valvular heart disease and sex disparities is needed. The camaraderie was incredible and the discussion...

Author

Julia Grapsa

Secure your grant for PCR London Valves

Are you attending the PCR Fundamentals Course? Apply for an Indirect Industry Supported Grant and get your #PCRLV registration fees covered! Limited grants available, and allocated on a first come first served basis!

Refine your practical skills, improve patient outcomes

Plenty of interactive learning opportunities are waiting for you, 4 Simulation and hands on spaces and 42 Simulation Based Learning sessions. Explore topics ranging from coronary imaging to mitral valve interventions and more!

EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data

21 May 2025

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...

EuroPCR 2025 – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial

21 May 2025

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...

Major EuroPCR 2025 LBT - 4D-ACS: one-month DAPT followed by dose reduction of prasugrel after drug-coated stent insertion in acute coronary syndrome

21 May 2025 – From EuroPCR 2025

In this EuroPCR 2025 interview, Davide Capodanno and Woong Chol Kang discuss antithrombotic therapy in patients with acute coronary syndromes, focusing on the design and outcomes of the 4D-ACS trial. They describe the patient population enrolled in the study and introduce the two de-escalation strategies investigated:...

Hotline from EuroPCR 2025 - Five-year outcomes from the Evolut low risk TAVR bicuspid study

21 May 2025 – From EuroPCR 2025

Simon Redwood and John Forrest exchange insights on the Evolut Low Risk Bicuspid Study, which explores transcatheter aortic valve replacement (TAVR) in younger, low-risk patients with bicuspid aortic valves—an anatomy often excluded from earlier trials.

They review the trial design, patient characteristics, and results, comparing outcomes with...

EuroPCR 2025: RESIL-Card achieves a major milestone - The resilience tool is ready for pilot testing!

20 May 2025

Launched in December 2023 by our community through the ‘We CARE Alliance’ and co-funded by the EU4Health work programme, the mission of the RESIL-Card project is to ensure that essential healthcare services for people with cardiovascular (CV) diseases are maintained during crises. Specifically, the project aims to...

SMT’s Supraflex Cruz shows consistent and robust clinical outcomes across key global studies presented at TCT 2025

29 Oct 2025

Jupiter Endovascular announces positive results from SPIRARE I first-in-human study presented at TCT 2025

26 Oct 2025

Meril Life Sciences presents one-year outcomes from the LANDMARK randomized controlled trial at PCR London Valves 2025

16 Nov 2025

Indirect Industry Supported Grants for #PCRLV

A limited number of grants covering onsite registration and accommodation are available for healthcare practitioners who meet our Industry Partners’ selection criteria, check your eligibility and apply by 12 September!